Classification and Diagnosis of Mastocytosis: Current Status
Overview
Authors
Affiliations
Mastocytosis is a disease characterized by an abnormal increase in mast cells. Manifestations of the disease are provoked in large part by the resultant increase in mast cell-derived mediators, which have a variety of local and systemic effects. Mastocytosis is variable in respect to the organ systems involved, clinical manifestations, and association with hematologic diseases. This has suggested the need for an improved classification scheme to allow assessment of prognosis and therapy. The heterogeneity of the disease patterns in mastocytosis strongly suggests that more than one biologic lesion may occur in the developmental sequence that leads to placement of mature mast cells in tissues.
Elvevi A, Elli E, Luca M, Scaravaglio M, Pagni F, Ceola S World J Gastroenterol. 2022; 28(29):3767-3779.
PMID: 36157547 PMC: 9367223. DOI: 10.3748/wjg.v28.i29.3767.
Effects of ibrutinib on proliferation and histamine release in canine neoplastic mast cells.
Gamperl S, Stefanzl G, Peter B, Smiljkovic D, Bauer K, Willmann M Vet Comp Oncol. 2019; 17(4):553-561.
PMID: 31286638 PMC: 6900099. DOI: 10.1111/vco.12520.
The Role of KIT Mutations in Anaphylaxis.
Coulson E, Zhou S, Akin C Curr Allergy Asthma Rep. 2019; 19(6):31.
PMID: 31028494 DOI: 10.1007/s11882-019-0863-5.
Mastocytosis presenting as cardiac emergency.
Ridolo E, Triggiani M, Montagni M, Olivieri E, Ticinesi A, Nouvenne A Intern Emerg Med. 2013; 8(8):749-52.
PMID: 24136074 DOI: 10.1007/s11739-013-1012-0.
Valent P, Arock M, Bonadonna P, Brockow K, Broesby-Olsen S, Escribano L Wien Klin Wochenschr. 2012; 124(23-24):807-14.
PMID: 23179435 DOI: 10.1007/s00508-012-0293-z.